USSTOCK.TODAY
Weekend. Closed Log in Sign up

Achieve Life Sciences Inc(QUIT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

QUIT
QUIT
New
Achieve Life Sciences Inc
At close Nov 20 at 4:00 PM ET (Korea 11/21 06:00)
$5.56
-0.31 ▼ -5.28%
Nov 20 at 5:56 PM ET (Korea 11/21 07:56)
$5.70
+0.14 ▲ +2.52%

Full metrics table

Index ⓘ RUTP/E ⓘ -EPS (ttm) ⓘ -1.38Insider Own ⓘ 32.16%Shs Outstand ⓘ 109.8MPerf Week ⓘ -12.03%
Market Cap ⓘ 0.58BForward P/E ⓘ -EPS next Y ⓘ 44.58%Insider Trans ⓘ -0.06%Shs Float ⓘ 69.8MPerf Month ⓘ -14.46%
Enterprise Value ⓘ 0.39BPEG ⓘ -EPS next Q ⓘ -0.2Inst Own ⓘ 66.07%Short Float ⓘ 25.97%Perf Quarter ⓘ -29.97%
Income ⓘ -0.11BP/S ⓘ -EPS this Y ⓘ -6.69%Inst Trans ⓘ 54.21%Short Ratio ⓘ 13.24Perf Half Y ⓘ 18.55%
Sales ⓘ 0.00BP/B ⓘ 3.38EPS next 5Y ⓘ -ROA ⓘ -86.44%Short Interest ⓘ 18.13MPerf YTD ⓘ 11.87%
Book/sh ⓘ 1.65P/C ⓘ 2.86EPS past 3/5Y ⓘ 32.06% 25.38%ROE ⓘ -104.23%52W High ⓘ -35.65% ($8.64)Perf Year ⓘ 43.3%
Cash/sh ⓘ 1.94P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -59.73%52W Low ⓘ 112.21% ($2.62)Perf 3Y ⓘ 0.91%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -0.17%Gross Margin ⓘ -Volatility(W/M) ⓘ 5.76% 6.46%Perf 5Y ⓘ -27.23%
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -ATR (14) ⓘ 0.4Perf 10Y ⓘ -99.48%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 10.49EPS Q/Q ⓘ 59.45%Profit Margin ⓘ -RSI (14) ⓘ 31.46Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 10.49Sales Q/Q ⓘ -SMA20 ⓘ -14.15% ($6.48)Beta ⓘ 2.42Target Price ⓘ $13.75
Payout ⓘ -Debt/Eq ⓘ 0.08Earnings ⓘ 2026/11/10SMA50 ⓘ -20.11% ($6.96)Rel Volume ⓘ 1.41Prev Close ⓘ $5.87
Employees ⓘ 28LT Debt/Eq ⓘ 0.03EPS/Sales Surpr. ⓘ 44.92% -SMA200 ⓘ -3.36% ($5.75)Avg Volume(3M) ⓘ 1.37MPrice ⓘ $5.56
IPO ⓘ 1995/10/12Option/Short ⓘ Yes/YesTrades ⓘ 10509Volume ⓘ 1,926,879Change ⓘ -5.28%
Company
QUIT QUITAchieve Life Sciences Inc | NASD | Biotechnology

🚭 A US-based late-stage clinical pharmaceutical company developing treatments for nicotine dependence. The company is developing cytisine, a plant-derived alkaloid compound, for two indications: smoking cessation and electronic cigarette withdrawal, and is conducting late-stage clinical trials and regulatory processes aiming for US FDA approval. Recently, the company has rebranded as AchieveRx and is focusing on preparations for commercialization.

Quote

Over the past 1 year, roughly in the middle

36% below its 1-year high.

Now $5.56
52w low$2.6252w high$8.64
52W Range49%
Volume ⓘ 1,926,879

Traded more than usual. That is 141% of its average volume.

C
Overall · average, with some caution
We judged 5 of the 8 questions below. 1 rate excellent and 3 need caution.
No data for valuation, earnings, dividends, or not applicable.
ETFs holding this stock 10 ETFs

Multiple ETFs hold this stock

Buying this ETF gives you exposure to this stock as well.

Peer comparison Biotechnology

It ranks #191 of 598 in the industry

Based on market cap of $577M.

FAQ

FAQ

QUIT belongs to the Healthcare sector and operates in the Biotechnology industry.

The market cap of QUIT is approximately $577M, ranking 2,907 within its sector.

QUIT has recorded a 52-week high of $8.64 and a low of $2.62.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels